Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Published on 20/03/202520/03/2025 by Top Pharmaceutical

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Dr. Awatef Sassi, Faculty of medicine of sousse, Tunisia

Dr. Awatef Sassi 🧬🔬 is a distinguished postdoctoral researcher at the Faculty of Medicine of Sousse, specializing in cardiovascular and metabolic research. She earned her Ph.D. in Biological Sciences (2018) from the Faculty of Science of Bizerte, following a Master’s in Vascular Diseases Biology (2011) and a Medical Biotechnology degree (2008). Dr. Sassi has contributed significantly to scientific advancements, securing a patent on anti-hypertensive properties of Rosmarinus officinalis and publishing in high-impact journals. She is actively involved in mentoring medical theses and conducting innovative research in biophysics and applied toxicology. 🌿📊

Publication Profile

Orcid

Education

Dr. Awatef Sassi is a distinguished scholar in biological sciences 🧬, biotechnology 🏥, and vascular diseases ❤️. With a Ph.D. in Biological Sciences 🎓, a Master’s in Vascular Disease Biology, and a Medical Biotechnology degree, she has demonstrated an unwavering commitment to scientific research 🔬. Her extensive expertise spans innovative biotechnological applications and advancements in vascular health, contributing significantly to the medical and scientific communities. Dr. Sassi’s dedication to excellence and groundbreaking research continues to shape the future of biotechnology and vascular medicine, making her a respected figure in the field 🌟.

Experience

Dr. Awatef Sassi’s postdoctoral research at the Faculty of Medicine in Sousse 🏥 has focused on cardio-pulmonary interactions 💓💨 and biophysics ⚛️, making significant contributions to biomedical sciences. As a dedicated mentor, she has supervised multiple medical theses 📚, showcasing her leadership in academia. Her patented innovation 🏅 on the antihypertensive activity of Rosmarinus officinalis 🌿 (TN 2023/0143) highlights groundbreaking research with potential clinical impact in hypertension treatment 💊. Through her pioneering work, Dr. Sassi continues to advance medical science, bridging research and practical healthcare solutions for improved cardiovascular health ❤️.

Professional Development

Dr. Awatef Sassi is a dedicated educator and researcher 🎓🔬, with extensive experience as a lecturer in analytical chemistry ⚗️. Her involvement in postgraduate training 📚 has strengthened expertise in HPLC/UPLC 💉, mass spectrometry 🧪, and data analysis (SPSS) 📊. Through her teaching and mentorship, she equips students and researchers with essential analytical and computational skills, fostering scientific excellence. Dr. Sassi’s commitment to professional development ensures that future scientists gain hands-on experience in advanced laboratory techniques, making a lasting impact in biotechnology, pharmacology, and medical sciences 🏥🌿.

Research Focus

Dr. Awatef Sassi’s research primarily focuses on phytomedicine 🌿, clinical nutrition 🥗, cardiovascular health ❤️, and pharmaceutical sciences 💊. Her work explores the therapeutic potential of medicinal plants like Rosmarinus officinalis and Nitraria retusa for conditions such as hypertension, obesity, and lipid disorders. Additionally, she has contributed to cardiovascular interventions 🏥, dermatological formulations, and transfusion medicine 🩸. Her studies include randomized clinical trials, pilot studies, and formulation research, highlighting her interdisciplinary approach to natural product-based therapy and clinical pharmacology. Her work significantly impacts personalized medicine, preventive healthcare, and alternative treatment strategies.

Publication Top Notes

The Effect of Rosmarinus officinalis L Infusion Supplementation on Blood Pressure Among Healthy Volunteers and Grade 1 Hypertensive Patients

Antiobesity and Hypolipidemic Potential of Nitraria retusa Extract in Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Exploring the Effects of Short-Term Daily Intake of Nitraria retusa Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults

Distal radial approach versus conventional radial approach: a comparative study of feasibility and safety

Formulation and evaluation of topical halofuginone gel using a novel <I>ex vivo</i> model

RHD genotyping and its implication in transfusion practice

M. Imad Damaj | Neuropharmacology | Best Researcher Award

Published on 20/03/202520/03/2025 by Top Pharmaceutical

M. Imad Damaj | Neuropharmacology | Best Researcher Award

Prof. Dr. M. Imad Damaj, Virginia Commonwealth University, United States

Prof. Dr. M. Imad Damaj is a distinguished pharmacologist specializing in pain, neuropathy, and drug dependence. A professor at Virginia Commonwealth University (VCU), he co-directs the Translational Research Initiative for Pain and Neuropathy. Holding a Ph.D. in Pharmacology from the University of Paris XI, he has made significant contributions to neuropharmacology and drug addiction research. An award-winning educator, he has received the VCU Award of Excellence and is a National Academy of Inventors inductee. His extensive work includes NIH study sections, journal editorial roles, and mentoring future scientists. 🌍📚🔬

Publication Profile

Scopus

Education

Prof. Dr. M. Imad Damaj 🎓 began his academic journey with a B.S. in Pharmacy from the University of St-Joseph (French Faculty of Medicine) in Beirut, Lebanon, in 1985. He then pursued an M.S. in Hospital Pharmacy (DESS) at the School of Pharmacy, University of Paris VI, France, in 1986. His passion for pharmacology led him to earn a Ph.D. in 1991 from the University of Paris XI, under the mentorship of Dr. Christian Jacquot. 🧪 His dissertation focused on the pharmacological and pharmacokinetic evaluation of COR3224, a novel antidepressant agent, in rats, contributing valuable insights to the field. 🧬

Experience

Prof. Dr. M. Imad Damaj 🧪 has an extensive background in training and research. He began as a Hospital Pharmacist at the Pediatric Parenteral Nutrition Unit, Necker Pediatric Hospital, Paris (1985-1986) and later became a Pharmacy Resident at Ste-Anne Neuropsychiatric Hospital (1986-1987). His academic journey included a predoctoral fellowship at the University of Paris XI (1987-1991) and a postdoctoral fellowship at the Medical College of Virginia (1991-1993). 🎓 Since 1994, he has been actively involved in teaching at Virginia Commonwealth University, covering pharmacology, drug dependence, and pain control, mentoring students in pharmacy, dentistry, and medical sciences.

Awards

Prof. Dr. M. Imad Damaj 🎓 has received numerous prestigious awards and honors throughout his career. In 1990, he earned the SARGET Laboratories Award for his research on antidepressants in rat brains. He received postdoctoral travel awards from ASPET (1992) and CPDD (1993). Recognized as an Outstanding Young Investigator in 1995, he continued to receive accolades, including multiple NIDA Travel Awards (1996, 1999) and the College de France Award (2001). 🌟 At VCU, he was named Professor of the Year (2014) and won multiple teaching awards. In 2023, he was inducted into the National Academy of Inventors. 🏅

Professional Activity

Prof. Dr. M. Imad Damaj 🧪 has been actively engaged in professional activities, serving as an ad hoc reviewer for esteemed journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology, and Neurochemistry International. Since 1993, he has contributed as a judge for the Virginia Junior Academy of Sciences and Virginia Academy of Sciences. 🎓 He has also participated in educational outreach, including the Mini-Med School of Virginia. From 2002-2018, he was on the Editorial Advisory Board for JPET, and in 2021, he became Associate Editor for Frontiers in Pain Research.

Research Focus

Prof. Dr. Mohamad Imad Damaj is a distinguished researcher in neuropharmacology 🧠💊, with a strong focus on nicotinic acetylcholine receptors (nAChRs) 🔬 and their role in addiction, pain, and neuropsychiatric disorders. His work explores the mechanisms of nicotine addiction 🚬, opioid withdrawal ⚠️, and neuropathic pain 🔥, employing advanced mouse models 🐭 to investigate behavioral and molecular responses. He has contributed significantly to understanding novel pharmacological interventions 💉, including PPARα agonists and α7 nicotinic receptor modulators. His research has broad implications for pain management, substance use disorders, and neuroprotection.

Publication Top Notes

Characterization of a novel oronasal-restricted nicotine vaping self-administration model in mice

New PPARα Agonist A190-Loaded Microemulsion for Chemotherapy-Induced Peripheral Neuropathy

Sulfonium Moieties as Ammonium Bioisosteres: Novel Ligands for the Alpha7 Nicotinic Acetylcholine Receptor

Identification of ethanol analgesia quantitative trait loci and candidate genes in BXD recombinant inbred mouse lines

Upregulation of the neuropeptide receptor calcitonin receptor-like in the spinal cord via MLL2 in a mouse model of paclitaxel-induced peripheral neuropathy

Voluntary nicotine consumption and reward in a subset of diversity outbred founder strains

Activation of α7 nicotinic receptors attenuated hyperalgesia and anxiety induced by palatable obesogenic diet withdrawal

Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic pain

Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice

The potential effect of α7 nicotinic receptors modulation on palatable food-induced dependence-like behaviors

Soufiene Bettaibi | Cardiovascular Pharmacology | Best Researcher Award

Published on 18/03/202518/03/2025 by Top Pharmaceutical

Soufiene Bettaibi | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Soufiene Bettaibi, International University of Rabat, UIR, Morocco

Assoc. Prof. Dr. Soufiene Bettaibi is a distinguished expert in Fluid Mechanics and Heat & Mass Transfer 🔥💧. He holds a Master’s and Ph.D. in these fields, earned through collaborations with the Faculty of Science of Tunis, CETHIL (INSA Lyon), and IAC-CNR (Rome) 🏛️. Currently, he serves as an Associate Professor at the Higher School of Energy Engineering, International University of Rabat (UIR), Morocco 🇲🇦. His research focuses on nanofluids, biomechanics, and energy systems ⚙️🧪, with numerous ISI-indexed publications 📚 and active participation in international conferences & projects 🌍🔍

Publication Profile

Google Scholar

Academic Background

Assoc. Prof. Dr. Soufiene Bettaibi 🎓 is a distinguished expert in Fluid Mechanics and Heat and Mass Transfer. He earned his Master’s and Ph.D. degrees through collaborative research with prestigious institutions, including the Faculty of Science of Tunis, CETHIL (INSA Lyon) 🇫🇷, and IAC-CNR (Rome) 🇮🇹. His strong academic foundation and extensive research contributions have positioned him as a key figure in advancing scientific knowledge in these specialized fields. Dr. Bettaibi’s expertise continues to drive innovation, shaping the future of fluid dynamics and thermal sciences with groundbreaking research and interdisciplinary collaborations. 🔬🔥

Research Impact

Assoc. Prof. Dr. Soufiene Bettaibi 🎓 is a dedicated researcher and educator at the Higher School of Energy Engineering, International University of Rabat (UIR) 🇲🇦. His expertise in Fluid Mechanics and Heat and Mass Transfer has led to groundbreaking research that enhances scientific understanding in these critical fields. Through his work, Dr. Bettaibi has made significant contributions to academia, fostering innovation and advancing knowledge in energy engineering. His research not only enriches the scientific community but also plays a crucial role in developing sustainable and efficient thermal systems for future applications. 🔬⚙️🔥

Conference Engagement

Assoc. Prof. Dr. Soufiene Bettaibi 📚 has made significant contributions to the scientific community through his numerous ISI-indexed publications, reflecting the depth and rigor of his research. In addition to his scholarly work, he actively engages in national and international conferences and workshops 🌍🎤, where he presents his findings and collaborates with experts worldwide. His participation in these events strengthens global scientific discourse, fosters innovation, and enhances interdisciplinary research in Fluid Mechanics and Heat and Mass Transfer. Dr. Bettaibi’s commitment to knowledge dissemination continues to inspire and drive advancements in his field. 🔬📖

Research Focus

Assoc. Prof. Dr. Soufiene Bettaibi focuses on computational fluid dynamics (CFD) 🌊, lattice Boltzmann method (LBM) 🧮, heat and mass transfer 🔥💨, and magnetohydrodynamics (MHD) 🧲. His research explores mixed convection flows in cavities 🏠, blood flow modeling in arteries 🩸, and multiphysics simulations 📊. He applies finite difference methods 📐 and mesoscopic modeling 🌀 to solve complex engineering and biomedical problems. His studies have significant applications in biomedical engineering 🏥, energy systems ⚡, and thermal management ❄️. Through his advanced numerical simulations, Dr. Bettaibi contributes to fluid dynamics innovation 🚀 and interdisciplinary scientific advancements 🔬.

Publication Top Notes

Hybrid LBM-MRT model coupled with finite difference method for double-diffusive mixed convection in rectangular enclosure with insulated moving lid

Hybrid lattice Boltzmann finite difference simulation of mixed convection flows in a lid-driven square cavity

Lattice Boltzmann simulation of mixed convection heat transfer in a driven cavity with non-uniform heating of the bottom wall

Magnetohydrodynamic blood flow study in stenotic coronary artery using lattice Boltzmann method

Numerical study of thermal diffusion and diffusion thermo effects in a differentially heated and salted driven cavity using MRT-lattice Boltzmann finite difference model

Numerical study of pulsatile thermal magnetohydrodynamic blood flow in an artery with aneurysm using lattice Boltzmann method (LBM)

MRT-lattice Boltzmann hybrid model for the double diffusive mixed convection with thermodiffusion effect

Double diffusive mixed convection with thermodiffusion effect in a driven cavity by lattice Boltzmann method

Double population lattice Boltzmann model for magneto-hydrodynamic blood flow in stenotic artery

Tadesse Tarik Tamir | Pharmaceutical Analysis | Best Researcher Award

Published on 18/03/202518/03/2025 by Top Pharmaceutical

Tadesse Tarik Tamir | Pharmaceutical Analysis | Best Researcher Award

Mr. Tadesse Tarik Tamir, College of Medicine and Health Sciences, University of Gondar, Ethiopia

Tadesse Tarik Tamir is a dedicated lecturer and researcher at the University of Gondar, Ethiopia 🎓. With a Master’s in Pediatrics and Child Health Nursing and an MPH in Epidemiology, he actively contributes to teaching, research, and community service. His expertise spans public health, epidemiology, and child healthcare 🏥. Tadesse has published several Q1-ranked research articles on childhood nutrition, vaccination, and PTSD in children 📑. Proficient in SPSS, STATA, R, and GIS 📊, he is committed to advancing healthcare research and education. His work continues to impact public health policies and child welfare across low- and middle-income countries 🌍.

Publication Profile

orcid

Education

Tadesse Tarik Tamir 🎓 is a dedicated healthcare professional from Gondar, Ethiopia 🇪🇹. He is currently pursuing an MPH in Epidemiology 🦠 at the University of Gondar (since November 2022). Previously, he earned an MSc in Pediatrics and Child Health Nursing 👶🩺 (2019–2021) and a BSc in Nursing 🏥 (2014–2018) from the same university. His commitment to academia also led him to obtain a Diploma in Higher Education 📚 (2021–2022). With a strong educational background and expertise in nursing and epidemiology, Tadesse is devoted to improving public health and child healthcare in Ethiopia. 🌍✨

Experience

Tadesse Tarik Tamir 🎓 is a dedicated educator and researcher at the University of Gondar 🇪🇹. Since July 2021, he has been serving as a Lecturer 🏫, actively engaged in teaching, research, and community service. Prior to this, he worked as an Assistant Lecturer 📚 (2019–2021), contributing to academic excellence and knowledge dissemination. His journey in academia began as a Graduate Assistant II 🏅 (2018–2019), where he honed his teaching and research skills. With a strong passion for education and public health, Tadesse continues to inspire students and contribute to impactful research in Ethiopia. 🌍✨

Networks and Membership

Tadesse Tarik Tamir 🎓 is an active contributor to academia and professional networks. Since 2016, he has served as an Editorial Board Member for BMC Public Health 📝, playing a vital role in scientific publishing. He has been a proud member of the Ethiopian Nursing Association (ENA) 🏥 since 2015, advocating for nursing excellence. His commitment to social impact extends to his role at the Menna Elderly and Mentally Challenging Support Center ❤️. Additionally, since 2021, he has been an Executive Member of the Ethiopian Teachers’ Association 📚, supporting educators and academic development in Ethiopia 🇪🇹. 🌍✨

Research Focus

Tadesse Tarik Tamir’s research focuses on public health 🏥, epidemiology 📊, and child health 👶 across low- and middle-income countries. His work extensively explores childhood vaccination 💉, nutritional health 🥦, infectious diseases 🦠, and maternal and neonatal mortality 👩‍🍼. He also investigates mental health disorders 🧠, particularly post-traumatic stress disorder (PTSD) in children. Through systematic reviews, meta-analyses, and spatial epidemiology, he provides critical insights into health disparities 🌍, aiming to influence policy decisions 📜 and improve healthcare outcomes. His high-impact Q1 journal publications 📄 reflect his leadership in global health research.

Publication Top Notes

Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A Meta-analysis of demographic and health survey reports between 2015 and 2025

Minimum dietary diversity and its determinants among lactating mothers in five Sub-Saharan African countries: A multilevel analysis

Spatial variation and predictors of anemia among women of reproductive age in Mozambique, 2022/23: a multiscale geographically weighted regression

Prevalence of depression among primary caregivers of patients with cancer in Africa: a systematic review and meta-analysis study

Only three out of ten women received adequate postnatal care in sub-Saharan Africa: evidence from 20 countries demographic and health surveys (2015–2022)

Determinants of pressure to conceive among reproductive age women in Sub-Saharan Africa: A multilevel analysis of recent Demographic and Health Surveys in five countries

Childhood wasting and associated factors in Africa: evidence from standard demographic and health surveys from 35 countries

Prevalence and Determinants of Home Delivery among Women with Easy Access to Health Facilities in Sub‑Saharan African Countries: A Multi‑level Mixed Effect Analysis

Xia Xiao | Pharmacodynamics | Best Researcher Award

Published on 18/03/202518/03/2025 by Top Pharmaceutical

Xia Xiao | Pharmacodynamics | Best Researcher Award

Assoc. Prof. Dr. Xia Xiao, Yangzhou University, China

Assoc. Prof. Dr. Xia Xiao is a distinguished researcher in veterinary microbiology at Yangzhou University. He earned his Ph.D. in Veterinary Science from South China Agricultural University (2015) 🎓, specializing in bacteriophage-mediated antibiotic resistance. His research focuses on antimicrobial pharmacokinetics, novel antimicrobial agents, and bacterial resistance mechanisms 🦠💊. A former visiting scholar at UCLA (2018-2019), Dr. Xiao has published extensively in high-impact journals 📚. His work contributes to the rational use of antibiotics and combating multidrug resistance, advancing veterinary and human medicine alike. 🏆🔍

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Xia Xiao is a leading veterinary microbiologist at Yangzhou University. He earned his Ph.D. in Veterinary Science from South China Agricultural University (2015) 🎓, specializing in bacteriophage-mediated antibiotic resistance. As a former visiting scholar at UCLA (2018-2019) 🌍, his research focuses on antimicrobial pharmacokinetics, novel antimicrobial agents, and bacterial resistance mechanisms 🦠💊. Since 2020, he has been an Associate Professor, contributing to advancements in antibiotic utilization and resistance control. His work plays a crucial role in improving both veterinary and human medicine. 📚

Experience

Assoc. Prof. Dr. Xia Xiao is a veterinary microbiologist at Yangzhou University, specializing in antimicrobial resistance 🦠💊. He earned his Ph.D. from South China Agricultural University (2015) 🎓, focusing on bacteriophage-mediated antibiotic resistance. As a Visiting Scholar at UCLA (2018-2019) 🌍, he expanded his research through international collaborations, enhancing his contributions to the global scientific community 🔬🤝. His work explores antibiotic pharmacokinetics, novel antimicrobial agents, and bacterial resistance strategies. Since 2020, he has been an Associate Professor, making impactful strides in veterinary and human medicine. 📚🏆

Focus Areas

Assoc. Prof. Dr. Xia Xiao is a veterinary microbiologist at Yangzhou University, specializing in antimicrobial resistance and antibiotic optimization 💊📊. He earned his Ph.D. from South China Agricultural University (2015) 🎓 and later expanded his research through international collaboration as a Visiting Scholar at UCLA (2018-2019) 🌍. His work focuses on pharmacokinetics-based antibiotic use, novel antimicrobial development, and strategies to combat bacterial resistance 🏥⚕️. His groundbreaking research on bacteriophage-mediated resistance transmission addresses global health challenges, making significant contributions to veterinary and medical microbiology. 📚🏆

Research Focus

Assoc. Prof. Dr. Xia Xiao’s research primarily focuses on antimicrobial resistance (AMR) 🦠💊, pharmacokinetics/pharmacodynamics (PK/PD) modeling 📊🧪, and bacterial resistance mechanisms 🔬🧫. Her work explores the role of resistance genes, such as mcr-1, blaNDM-5, and tet(X4), in multidrug-resistant pathogens, including Klebsiella pneumoniae and Escherichia coli. She investigates novel strategies to combat AMR, including using natural compounds 🌿, repurposed drugs 💡, and PK/PD-based optimization 📉📈. Her research has significant implications for developing effective treatments against drug-resistant infections in both humans and animals 🏥🐾.

Publication Top Notes

DNA Polymerase IV dinB Favors the Adaptive Fitness of mcr-carrying Bacteria Through a Negative Feedback Regulatory Mechanism

Acetylshikonin Derived From Arnebia euchroma (Royle) Johnst Kills Multidrug-Resistant Gram-Positive Pathogens In Vitro and In Vivo

Acetylshikonin reduces the spread of antibiotic resistance via plasmid conjugation

The Food Additive Benzaldehyde Confers a Broad Antibiotic Tolerance by Modulating Bacterial Metabolism and Inhibiting the Formation of Bacterial Flagella

Gramine sensitizes Klebsiella pneumoniae to tigecycline killing

Characterization of a cfr-bearing integrative and conjugative element in Proteus cibarius coharbouring tet(X6) on the chromosome

Abhay Pandey | Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on 13/03/202513/03/2025 by Top Pharmaceutical

Abhay Pandey | Herbal Medicine and Nutraceuticals | Best Researcher Award

Prof. Dr. Abhay Pandey, University of Allahabad, Prayagraj, India

Prof. Dr. Abhay Pandey is a distinguished biochemist 🧬 and professor at the University of Allahabad 🏛️, specializing in oxidative stress, free radical biology, and natural product biochemistry 🌿. With a Ph.D. in Biochemistry (1993) 🎓, he has over 29 years of academic experience 📚, supervising 12 Ph.D. scholars and 45 M.Sc. dissertations. He has held key administrative roles, including Head of Biochemistry and Assistant Dean. A fellow of NASI and SBC India, he has received prestigious awards 🏆 like the Dr. Sarvepalli Radhakrishnan Education Promotion Award. His impactful research continues to shape the scientific community 🌟.

Publication Profile

Google Scholar

Education

Prof. Dr. Abhay Pandey holds an impressive academic background in life sciences. 🎓 He earned his B.Sc. in Zoology, Botany, and Chemistry (1982) and an M.Sc. in Biochemistry (1984) from the University of Allahabad, both with first-division honors. 🏅 He qualified for the UGC JRF-NET in Life Sciences (1986) and pursued a Ph.D. (1993) on the “Study of interaction of metal ions with biologically important adenine nucleotides.” 🧬 Additionally, he completed DIM (1997) and PGDIM (1998) from IGNOU. 📚 A recipient of the National and State Merit Scholarships, he also availed JRF & SRF for his research contributions. 🏆

Experience

Prof. Dr. Abhay Pandey has undergone extensive professional training in advanced biotechnological fields. 🧬 He participated in workshops on DNA vaccines (2002) and Recombinant DNA Technology for Vaccine Development (2001) at IVRI, Bareilly. Additionally, he trained in ISO 9000 QA System implementation (1998). ✅ His administrative roles include serving as Head of the Biochemistry Department at the University of Allahabad (2017–2019) and SBSPGI, Dehradun (2002–2004). 🎓 He has held key positions such as Assistant Proctor, Assistant Dean (Students’ Welfare), Warden, and Chairman of multiple university committees. 🏛️ He also contributes as DBT Nominee for Biosafety at MNNIT, Prayagraj. 🔬

Awards

Prof. Dr. Abhay Pandey has received numerous prestigious honors for his contributions to science and education. 🏆 He serves as Associate Editor-in-Chief for VEGETOS (Springer) and as Associate Editor for BMC Complementary and Alternative Medicine (Springer). 📖 He was a Guest Associate Editor for Frontiers in Pharmacology (2020–21). His accolades include the Dr. Sarvepalli Radhakrishnan Education Promotion Award (2019) 🎖️ and the Distinguished Scientist Award (2016) by SPR. He has been recognized as a Distinguished Academician (2012) and received the Fellow Award (2011–12). ✨ In 2010, he was granted an International Travel Award by DST, India, to visit Spain. ✈️

Research Focus

Prof. Dr. Abhay Pandey is a distinguished researcher in phytochemistry 🌿, medicinal chemistry 🧪, and natural product pharmacology 💊. His research primarily focuses on the biological activities of flavonoids, polyphenols, and other plant-derived compounds, particularly their antioxidant 🛡️, antimicrobial 🦠, anticancer 🎗️, and anti-inflammatory 🔬 properties. He has extensively studied the therapeutic potential of medicinal plants 🌱, their role in gut microbiota modulation 🦠, and their application in metabolic disorders 🔄. His work also explores histone deacetylase inhibitors for cancer treatment and the AMPK pathway in diabetes. His contributions significantly advance phytomedicine and natural drug discovery 🏆

Publication Top Notes

Chemistry and biological activities of flavonoids: an overview

Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency

Bauhinia variegata leaf extracts exhibit considerable antibacterial, antioxidant, and anticancer activities

Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models

Therapeutic potential of Aloe vera-A miracle gift of nature

Scientific validation of the medicinal efficacy of Tinospora cordifolia

Inhibitory activity of Indian spice plant Cinnamomum zeylanicum extracts against Alternaria solani and Curvularia lunata, the pathogenic dematiaceous moulds

Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy

Antifungal and antioxidative potential of oil and extracts derived from leaves of Indian spice plant Cinnamomum tamala

Anti-staphylococcal activity of a pan-tropical aggressive and obnoxious weed Parthenium histerophorus: an in vitro study.

Free radicals: health implications and their mitigation by herbals

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Published on 12/03/202512/03/2025 by Top Pharmaceutical

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Dr. nisreen kaddim, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nisreen Kaddim Radi is an Assistant Professor at the University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🧬. Her research focuses on antimicrobial resistance, food safety, and innovative antibacterial films for medical applications 🏥. She has presented at international conferences and published extensively in high-impact journals 📚. Passionate about advancing science, she integrates computational and experimental approaches to explore anticancer and antibacterial agents ⚗️. With a commitment to research and education, Dr. Nisreen inspires students and contributes to scientific innovation 🌍.

Publication Profile

Google Scholar

Professional Background

Dr. Nisreen Kaddim Radi 🎓 is an Assistant Professor at the College of Science for Women, University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🦠, with a focus on food safety and packaging 🍱. She is a member of the Arab Association for Science and Technology, Iraq branch, and serves on the Educational Guidance Committee at her college. Dr. Nisreen has published numerous research papers and actively participates in global conferences 🌍, including the 2022 International Conference on Sustainable Development Goals in Istanbul, ICAB 2022 at the University of Basrah, and ICAB2 2024, where she presented her studies on antimicrobial resistance, genetic variation, and immunological research

Memberships

Dr. Nisreen Kaddim Radi 🔬 is a dedicated researcher with significant contributions to molecular biology, genetics, and virology 🧬. Although she does not hold editorial positions or industry collaborations, her active engagement in scientific research strengthens her impact in the field. As a member of the Arab Association for Science and Technology 🌍, she remains connected to a network of experts, enhancing her academic and professional credibility. Through her research and participation in international conferences, Dr. Nisreen continues to contribute valuable insights to the scientific community, particularly in food safety and antimicrobial resistance 🦠.

Innovation in Methodology

Dr. Nisreen Kaddim Radi 🔬 combines computational simulations with experimental studies to develop innovative methods for enhancing the effectiveness of antibacterial and anticancer agents 🦠🎗️. Her dual-approach methodology integrates cutting-edge technology with practical applications, demonstrating a high level of scientific innovation 🚀. By bridging computational modeling with real-world experimentation, she contributes to advancing medical and pharmaceutical research, aligning perfectly with the award’s objectives 🏆. Her work not only improves therapeutic outcomes but also paves the way for more efficient and targeted treatments, reinforcing her role as a leading researcher in molecular biology and biotechnology 🧬.

Research Excellence

Dr. Nisreen Kaddim Radi 🔬 is pioneering the development of antibacterial films by integrating nanomaterials, polymers, and plant extracts 🌱🦠. Her innovative approach has profound implications for both medical and industrial applications 🏥🏭, positioning her at the forefront of antibacterial and anticancer material research 🎗️. Her groundbreaking study, Integrative Computational and Experimental Study of Propolis, Polyvinyl Alcohol, and Alhagi maurorum Complex as Anticancer and Antibacterial Agents 📜, showcases a multidisciplinary methodology, blending computational modeling with experimental validation 💻⚗️. This research enhances therapeutic potential, contributing to the advancement of novel biomedical materials and precision-targeted treatments 🚀.

Research Focus

Dr. Nisreen Kaddim Radi’s research primarily focuses on medical microbiology 🦠, immunology 🧬, and infectious diseases 🏥. Her work extensively explores viral infections such as Varicella Zoster Virus (VZV) 🏵️, Human Papillomavirus (HPV) 🎗️, and Hepatitis B Virus (HBV) 🦠, investigating genetic susceptibility and immune response. She also examines bacterial resistance 🧫, particularly in foodborne pathogens like E. coli, and studies immunological markers 🧪 in various infections. Her contributions in genetic polymorphisms 🔬, cytokine responses 🌡️, and molecular typing of pathogens highlight her expertise in understanding disease mechanisms and improving diagnostic approaches in infectious diseases and immunological disorders.

Publication Top Notes

Investigation of oxidative stress in patient with Varicella Zoster Virus (VZV) infection

Human genetic variation susceptibility associated with HBV: analysis of genetic markers susceptibility to hepatitis b among patients in babylon province

Genetic study of TORCH infections in women with bad obstetric history: multiplex polymerase chain reaction for detection of common pathogens and agents of congenital infections

Evaluation of CD4 and CD8 in Patients Infected with Genital Wart Caused by Human Papilloma Virus in Babylon Province/Iraq

Evaluation of serum IgE, TNF alpha at patients with genital warts, Iraq.

Immunological Study for Patient with Verruca Vulgaris and Verruca Plana Caused by HPV in Hilla/Iraq

The effect of manganese poisoning on the histological structure of testis in male Swiss mice

Bacteriological Study of Tonsillitis Patients and Estimation of Concentrations of Certain Immunological Parameters.

The distribution of antimicrobial resistance and the presence of virulence genes in Escherichia coli isolated from frozen chicken meat in Iraq

Henryk Mazurek | Precision Medicine | Best Researcher Award

Published on 12/03/202512/03/2025 by Top Pharmaceutical

Henryk Mazurek | Precision Medicine | Best Researcher Award

Prof. Henryk Mazurek, National Tuberculosis and Lung Diseases Institute, Department of Pneumonology and Cystic Fibrosis, Poland

Prof. Henryk Mazurek is a distinguished pulmonologist, allergologist, and pediatrician specializing in pediatric pulmonology and respiratory diseases. He serves as the Head of the Department of Pneumonology and Cystic Fibrosis at the National Tuberculosis and Lung Diseases Institute, Poland 🇵🇱. With over 60 original research articles and extensive contributions to medical literature 📚, he has significantly advanced the understanding of chronic respiratory diseases, asthma, and cystic fibrosis. A member of esteemed scientific societies 🌍, he actively collaborates internationally and leads impactful research projects. His work in AI-assisted diagnostics and pulmonary care is shaping the future of respiratory medicine. 🚀

Publication Profile

Scopus

Professional Background

Professor Henryk Mazurek is a distinguished pulmonary disease specialist, allergologist, pediatrician, and pediatric pulmonology expert 🩺. He completed postgraduate studies in respiratory pathophysiology in France 🇫🇷 and holds the title of Full Professor in medical and health sciences 🎓. As an academic, he teaches nursing and postgraduate medical training in pediatrics, allergology, and lung diseases. He has authored and co-authored over 60 original articles, 100+ textbook chapters, and numerous scientific publications 📚. A sought-after lecturer, he shares his expertise at medical conferences, educating physicians and healthcare professionals worldwide 🌍.

Memberships

Prof. Henryk Mazurek is an esteemed member of several prestigious scientific organizations, fostering international collaboration in respiratory medicine 🌍🫁. He holds a combined membership in the European Respiratory Society (ERS) / Polish Respiratory Society, along with memberships in the Polish Society of Allergology and the Polish Society of Pediatric Pulmonology, where he is an honorary member 🎖️. For many years, he contributed to the Scientific Council of the Institute of Tuberculosis and Lung Diseases in Warsaw 🏥. Additionally, he served on the Main Boards of the Polish Society of Allergology (2015-2021) and the Polish Society of Cystic Fibrosis (2014-2018) 📚.

Industry Projects

Prof. Henryk Mazurek has actively contributed to over 50 industry-sponsored clinical trials, showcasing his expertise in applied research 🔬. His consultancy work plays a crucial role in bridging academic research with real-world healthcare applications, particularly in advancing treatment strategies for cystic fibrosis 🫁. Through his collaborations with pharmaceutical and medical device companies 💊🩺, he has successfully translated research findings into clinical practice, improving patient outcomes. His dedication to innovation and evidence-based solutions continues to shape the future of respiratory medicine, reinforcing his impact on both academia and industry. 🌍

Research Focus

Prof. Henryk Mazurek’s research primarily focuses on respiratory diseases 🫁, particularly in cystic fibrosis 🧬, pediatric pulmonology 👶, and ventilator-associated pneumonia 🏥. His work explores innovative AI-facilitated home monitoring 🤖 for cystic fibrosis, childhood asthma treatments 🌬️, and the effects of medications like Gabapentin on post-operative pain 💊. He has also studied risk factors for pneumonia 🦠 and strategies for its prevention in ventilated patients. His expertise lies in pulmonary infections, inflammatory biomarkers, and personalized medicine 🧑‍⚕️. His contributions significantly impact respiratory healthcare, enhancing diagnostic and therapeutic approaches for both pediatric and adult patients.

Publication Top Notes

AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations

Childhood asthma treatment based on indirect hyperresponsiveness test: Randomized controlled trial

The Effects of Gabapentin on Post-Operative Pain and Anxiety, Morphine Consumption and Patient Satisfaction in Paediatric Patients Following the Ravitch Procedure—A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial

Risk Factors and Protective Factors against Ventilator-Associated Pneumonia—A Single-Center Mixed Prospective and Retrospective Cohort Study

Automatic continuous control of cuff pressure and subglottic secretion suction used together to prevent pneumonia in ventilated patients—a retrospective and prospective cohort study

Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6

Edwin Posadas | Precision Medicine | Best Researcher Award

Published on 12/03/202512/03/2025 by Top Pharmaceutical

Edwin Posadas | Precision Medicine | Best Researcher Award

Dr. Edwin Posadas, Cedars-Sinai Cancer, United States

Dr. Edwin M. Posadas is a distinguished oncologist and urologist specializing in prostate cancer research and treatment. He is a Professor at Cedars-Sinai Medical Center and UCLA, co-Director of the Cancer Therapeutics Program, and Medical Director of the Urologic Oncology Program. A Johns Hopkins graduate, he trained at the NIH and University of Michigan. Dr. Posadas has earned numerous accolades, including Castle Connolly Top Doctor and Sigma Xi Honors. An active researcher, mentor, and leader in oncology, he contributes to multiple scientific committees and journals, shaping the future of cancer care. 📚🔬✨

Publication Profile

orcid

Education

Dr. Edwin Posadas 🎓 began his academic journey at Johns Hopkins University, earning dual B.E.S. degrees in Biomedical and Chemical Engineering (1993) with summa cum laude honors. His studies focused on biological transport systems and physiological fluid mechanics. He then pursued his M.D. at Johns Hopkins School of Medicine (1998) 🩺, followed by an internship and residency at the University of Michigan Medical Center (2001) 🏥. Further specializing, he completed a fellowship in Medical Oncology and Hematology (2005) 🧬 at the National Cancer Institute & National Heart, Lung, and Blood Institute, solidifying his expertise in cancer research and treatment. 🔬💙

Professional Associations

Dr. Edwin Posadas 🩺 is an esteemed member of numerous professional associations and scholarly societies, reflecting his dedication to oncology, urology, and medical ethics. He joined the American Medical Association (1993) 🏥, Association of Philippine Physicians of America (1998) 🇵🇭, and American College of Physicians (1998) 🩻, later becoming a Fellow (2010) 🎖️. His contributions extend to the American Society of Clinical Oncology (2001) 🧬, American Association for Cancer Research (2001) 🔬, and European Society of Medical Oncology (2012) 🌍. He also actively participates in cancer research initiatives, including the Cancer Moonshot Program (2016) 🚀 and the Medical Oncology Association of Southern California (2022) 🌿.

Achievements

Dr. Edwin Posadas 🩺 has built a distinguished career in internal medicine and medical oncology, dedicated to advancing patient care and cancer research. In 2001, he became certified in Internal Medicine 🏥, laying the foundation for his expertise in diagnosing and managing complex diseases. His passion for oncology led him to further specialize, earning his Medical Oncology certification in 2019 🧬🎗️. With decades of experience, he remains committed to innovative cancer treatments, translational research, and personalized patient care, making significant contributions to the oncology community through clinical practice, research, and professional collaborations. 🔬💙

Research Focus

Dr. Edwin M. Posadas is a distinguished researcher specializing in prostate cancer 🔬, metastasis 🧬, and nanotechnology-based diagnostics 🏥. His work focuses on understanding the molecular determinants of metastasis in prostate cancer, particularly liver and visceral metastases. He has contributed to the development of nanotechnology solutions for early cancer detection 🩸 and circulating tumor cell profiling. His research also explores the role of FYN kinase in cancer growth and motility. With multiple grants from the National Cancer Institute and Congressionally Directed Medical Research Programs, his pioneering work is advancing precision oncology and metastasis prevention in prostate cancer patients. 🎗️

Publication Top Notes

Determinants of Liver Metastasis

A Nanotechnology Solution for Early Detection of Micrometastatic Prostate Cancer After Radical Prostatectomy

A blood test to identify prostate cancer patients at risk for visceral metastasis

Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling

FYN Is a Key Regulator of Metastasis in Prostate Cancer

Targeting FYN in Prostate Cancer: A Key Regulator of Growth and Motility

KYU SHIK MUN | Personalized Medicine | Best Researcher Award

Published on 11/03/202511/03/2025 by Top Pharmaceutical

KYU SHIK MUN | Personalized Medicine | Best Researcher Award

Assist. Prof. Dr. KYU SHIK MUN, Cedars-Sinai Medical Center, United States

Assist. Prof. Dr. Kyu Shik Mun is a distinguished researcher in cystic fibrosis (CF) and biomedical engineering 🧬. As a Principal Investigator and Co-Director, he has led groundbreaking projects on CF-related diabetes, organ-on-a-chip models, and personalized CF therapy 🏥. His work, funded by organizations like the Cystic Fibrosis Foundation and Vertex Pharmaceuticals, has yielded significant patents and high-impact publications 📑. With 733 citations, an h-index of 10, and an i10-index of 10, Dr. Mun continues to drive innovations in CF research, bridging biomedical science and translational medicine 🔬.

Publication Profile

Google Scholar

Professional Background

Assist. Prof. Dr. Kyu Shik Mun earned his Ph.D. in the Materials Science and Engineering Program at the University of Cincinnati 🎓. In 2016, he joined the Cystic Fibrosis Research Center at Cincinnati Children’s Hospital, where he pioneered a microfluidic-based organ-on-chip program from scratch 🏥🧬. His groundbreaking research focused on studying cystic fibrosis and related disorders. In 2021, he was promoted to Assistant Professor at Cedars-Sinai 🏆, where he continues to advance in vitro cell culture models using organ-on-chip technology and 3D bioprinting 🖨️🔬, contributing to innovative solutions in biomedical research and personalized medicine.

Awards

Assist. Prof. Dr. Kyu Shik Mun has received numerous prestigious honors and awards throughout his academic and professional journey 🎖️. He was awarded multiple Outstanding Grade Scholarships at Gangneung National University 🏅 (2000–2009) and recognized for excellence with department and presidential awards 🏆. His achievements include a scholarship from the Korean Broadcasting System 📺 and the Korea Research Foundation 🌏. During his Ph.D. at the University of Cincinnati, he earned a University Graduate Scholarship 🎓 (2010–2014). His research has been recognized by the American Gastroenterological Association and the Cystic Fibrosis Foundation 🧬, receiving multiple Best Abstract and Early Career Investigator awards (2017–2024) 🥇.

Experience

Assist. Prof. Dr. Kyu Shik Mun has been actively involved in non-clinical teaching, contributing to journal clubs and lab mentoring 📚🎤. He has delivered key presentations on organ-on-a-chip technology 🧬, including talks at Cincinnati Children’s Hospital (2020) and Cedars-Sinai (2021) 🏥. His mentorship spans postdoctoral fellows, research associates, and Ph.D. students, guiding projects in 3D bioprinting 🖨️ and patient-derived lung-on-a-chip models 🌬️. Since 2016, he has mentored 15 summer and rotation students—including high school, college, Ph.D., and MD candidates—on fabricating organ-on-a-chips and culturing cells, fostering the next generation of biomedical researchers 🔬.

Research Focus

Assist. Prof. Dr. Kyu Shik Mun’s research primarily focuses on nanotechnology 🧪, biosensors 🧫, and biomedical engineering 🏥. His work spans optical interferometric biosensors for label-free detection, organ-on-a-chip models for diseases like cystic fibrosis 🫁, and TiO₂ nanotube arrays for applications in solar cells ☀️ and photocatalysis. He also explores drug discovery 💊 by targeting molecular pathways in cystic fibrosis and related disorders. His interdisciplinary research integrates materials science 🏗️, biophysics ⚛️, and microfluidics 🔬 to develop innovative medical technologies, aiming to advance precision medicine 🎯 and renewable energy solutions 🌱.